Viewing nowDonepezil Hydrochloride 10 mg Tablets (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Hyubist Pharmaceutical Co., Ltd.

MFDS item code 201803529 · Approved 2018.08.29 · Insurance code 628801180
Treatment of symptoms of Alzheimer-type dementia
This medicine is used in the treatment of symptoms of Alzheimer's type dementia.
○ Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, consider taking this medicine in the morning. Since donepezil reaches steady-state concentrations 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. If treatment with this medicine is discontinued, its effects gradually diminish, and no rebound effect occurs after abrupt discontinuation. ○ Female patients aged 85 years or older with low body weight: Because adverse reactions occur more frequently, careful monitoring is required. Elderly women with low body weight should not exceed 5 mg daily.
○ Children: There is no experience with use in children.
This medicine contains Donepezil Hydrochloride Hydrate as its active ingredient and is used to treat symptoms of Alzheimer's type dementia. This medicine should not be administered to certain patients. For example, patients who are allergic to this medicine or its components, women who are pregnant or may become pregnant, nursing mothers, and those with lactose intolerance or specific genetic metabolic disorders should not take this medicine. Patients with heart disease or a slow heart rate, a history of peptic ulcers or those taking non-steroidal anti-inflammatory drugs, those with asthma or obstructive lung disease, patients with extrapyramidal disorders such as Parkinson's disease, and those allergic to certain dyes included in this medicine should use it with caution. This medicine can cause serious side effects such as heart-related problems, gastrointestinal bleeding, liver dysfunction, cerebrovascular disorders, movement disorders, neuroleptic malignant syndrome, rhabdomyolysis, respiratory distress, acute pancreatitis, acute renal failure, and sudden death, so immediate consultation with a doctor should be sought if any symptoms arise. In addition, this medicine can cause various side effects such as fatigue, dizziness, nausea, vomiting, diarrhea, decreased appetite, insomnia, headache, muscle pain, and rash, and particular attention should be paid to cardiovascular abnormalities such as arrhythmias, bradycardia, and heart block. This medicine is only approved for the treatment of Alzheimer's type dementia and is not approved for other types of dementia or memory disorders. Treatment should be conducted under the supervision of an experienced physician, and the treatment effect should be evaluated regularly. Patients with heart disease or a history of QT interval prolongation may require an electrocardiogram while taking this medicine, and caution should be exercised regarding drug interactions. In particular, the efficacy may change when used in conjunction with drugs that affect the CYP3A4 and CYP2D6 enzymes, so consultation with a physician is necessary. Women who are pregnant or breastfeeding are advised not to take this medicine, and if it is absolutely necessary to take it, it is preferable to consult experts and discontinue breastfeeding. Safety in children has not been established, and therefore this medicine should not be used in children. In the event of overdose, severe symptoms such as nausea, vomiting, bradycardia, hypotension, respiratory depression, and seizures may occur, requiring immediate visit to a medical institution, and atropine may be used as an antidote. This medicine should be kept out of reach of children and should not be transferred to other containers, as this can adversely affect quality.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent air exposure and is best kept at room temperature between 1 and 30 degrees Celsius. This ensures the maintenance of the medicine's efficacy and safety.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Hyubist Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.